Invention Grant
- Patent Title: Topical formulation for a JAK inhibitor
-
Application No.: US16566625Application Date: 2019-09-10
-
Publication No.: US10758543B2Publication Date: 2020-09-01
- Inventor: Bhavnish Parikh , Bhavesh Shah , Krishnaswamy Yeleswaram
- Applicant: Incyte Corporation , Incyte Holdings Corporation
- Applicant Address: US DE Wilmington
- Assignee: INCYTE CORPORATION
- Current Assignee: INCYTE CORPORATION
- Current Assignee Address: US DE Wilmington
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner
- Main IPC: A61K31/519
- IPC: A61K31/519 ; A61K9/107 ; A61K47/06 ; A61K47/10 ; A61K47/14 ; A61K47/24 ; A61K47/26 ; A61K47/36 ; A61K9/00
Abstract:
This invention relates to pharmaceutical formulations for topical skin application comprising (R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile, or a pharmaceutically acceptable salt thereof, and use in the treatment of skin disorders.
Public/Granted literature
- US20200046707A1 TOPICAL FORMULATION FOR A JAK INHIBITOR Public/Granted day:2020-02-13
Information query
IPC分类:
